PHARMASIN 50 solution for injection 50 mg/ml България - български - БАБХ (Българска агенция по безопасност на храните)

pharmasin 50 solution for injection 50 mg/ml

БИОВЕТ АД - Тилозин - инжекционен разтвор - 50 mg/ml - говеда, кози, котки, кучета, овце, свине

TYLOVET 10% premix for medicated feed for chickens, turkeys, calves for fattening 100 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

tylovet 10% premix for medicated feed for chickens, turkeys, calves for fattening 100 mg/g

Биовет АД - Тилозин (под формата на фосфат) - премикс за медикаментозен фураж - 100 mg/g - пилета, пуйки, телета

TYLOVET 25% premix for medicated feed for chickens, turkeys, calves for fattening 250 mg/g България - български - БАБХ (Българска агенция по безопасност на храните)

tylovet 25% premix for medicated feed for chickens, turkeys, calves for fattening 250 mg/g

Биовет АД - Тилозин (под формата на фосфат) - премикс за медикаментозен фураж - 250 mg/g - пилета, пуйки, телета

Fampyra Европейски съюз - български - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - Множествена склероза - Други лекарства в нервната система - fampyra е показан за подобряване на ходене при възрастни пациенти с множествена склероза с ходене увреждане (разширена увреждане състоянието мащаб 4-7).

Tysabri Европейски съюз - български - EMA (European Medicines Agency)

tysabri

biogen netherlands b.v. - натализумаб - Множествена склероза - Селективни имуносупресори - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 и 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Fingolimod Mylan Европейски съюз - български - EMA (European Medicines Agency)

fingolimod mylan

mylan ireland limited - финголимод хидрохлорид - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 и 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.

Aubagio Европейски съюз - български - EMA (European Medicines Agency)

aubagio

sanofi winthrop industrie - teriflunomide - Множествена склероза - Селективни имуносупресори - aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).